CLINICAL CENTERS FOR FEASIBILITY STUDIES ON RETINOID TRE

维甲酸 TRE 可行性研究临床中心

• 批准号: 6286796
• 负责人: JOE WESLEY RAMSDELL
• 金额: $ 21.6万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN DIEGO
• 依托单位国家: 美国
• 财政年份: 1999
• 资助国家: 美国
• 起止时间: 1999-09-30 至 2002-09-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6286796
• 关键词: clinical research; clinical trials; drug administration rate /duration; emphysema; experimental designs; health science research analysis /evaluation; human subject; human therapy evaluation; nutrition related tag; outcomes research; patient /disease registry; respiratory disorder chemotherapy; retinoate; vitamin therapy

The overall objective of the Feasibility of Retinoic Acid Treatment in Emphysema (FORTE) study is to conduct preliminary studies at 5 clinical centers preparatory to conducting a randomized, controlled, clinical trial on the efficacy of retinoic acid therapy in the management of emphysema. Objectives are to identify optimal patient populations, drugs and dosing schedules, and outcome measures for a large study, if indicated. This project serves as a clinical center for the study.

维甲酸治疗肺气肿可行性研究(FORTE)的总体目标是在5个临床中心进行初步研究，准备对维甲酸治疗肺气肿的疗效进行随机对照临床试验。目标是为一项大型研究确定最佳的患者群体、药物和剂量计划，以及结果测量(如果需要)。该项目作为该研究的临床中心。